跳至主要内容
临床试验/CTRI/2020/12/029540
CTRI/2020/12/029540尚未招募2 期

The efficacy and safety of intrauterine Misoprostol during Cesarean section in prevention of Primary Postpartum Hemorrhage-A Randomized Controlled Trial

Dr Nasreen Noor0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Gestational age of 37-40 completed weeks
  • Singleton pregnancy
  • Uncomplicated pregnancy
  • No contraindications to prostaglandins
  • No history of coagulopathy
  • Accepting to participate in the study

排除标准

  • Women with anemia(haemoglobin <8g)
  • Preterm pregnancy
  • Postterm pregnancy
  • Antepartum haemorrhage
  • History of Coagulopathy/preexisting maternal hemorrhagic disease

研究者

发起方
Dr Nasreen Noor

相似试验